Skip to main content
PMC home page
American Journal of Alzheimer's Disease and Other Dementias logoLink to American Journal of Alzheimer's Disease and Other Dementias
. 2005 May-Jun;20(3):144–150. doi: 10.1177/153331750502000303

Evidence that immunoglobulin-positive neurons in Alzheimer's disease are dying via the classical antibody-dependent complement pathway

Michael R D'Andrea 1
PMCID: PMC10833268  PMID: 16003929

Abstract

A recent study provided evidence that immunoglobulins (Igs) are not only present in Alzheimer's disease (AD) brains, but are also immunohistochemically detected in and/or on a particular population of pyramidal neurons that appeared morphologically degenerative in contrast to neighboring normal-appearing Ig-negative neurons.1 Because little has been reported about these Ig-positive neurons, the objectives of this study were to characterize the inflammatory profile of these neurons in the AD brain by determining if they possess complement components and are associated with reactive microglia. The data showed that the Ig-positive neurons had complement C1q and C5b-9 proteins and appeared degenerative. Furthermore, D-related human leukocyte antigen (HLA-DR)–positive fibers of reactive microglia were spatially closer (p < 0.001) and often in contact with the Ig-positive neurons than the Ig-negative neurons. Collectively, these data suggest that the Ig-positive neurons detected in AD brains are dying from the processes of the antibody-induced classical complement pathway.

Keywords: Alzheimer's disease, autoimmune disease, complement, classical pathway, immunoglobulin, C1q, C5b-9, immunohistochemistry, neurodegeneration

Full Text

The Full Text of this article is available as a PDF (9.7 MB).

Some of this work was presented as a poster at the International Alzheimer's Disease Meeting in Philadelphia, Pennsylvania on July 20, 2004.

References

  1. D'Andrea MR: Evidence linking neuronal cell death to autoimmunity in Alzheimer's disease. Brain Res. 2003; 982: 19-30. [DOI] [PubMed] [Google Scholar]
  2. D'Andrea MR: Add Alzheimer's disease to the list of autoimmune diseases. Med Hypotheses. 2005; 64(3): 458-463. [DOI] [PubMed] [Google Scholar]
  3. Emmerling MR, Watson MD, Ruby CA, et al.: The role of complement in Alzheimer's disease pathology. Biochem Biophys Acta. 2000; 1502: 158-171. [DOI] [PubMed] [Google Scholar]
  4. Webster S, Lue LF, Brachova L, et al.: Molecular and cellular characterization in the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiol Aging. 1997; 18: 415-421. [DOI] [PubMed] [Google Scholar]
  5. D'Andrea MR, Nagele RG, Wang H-Y, et al.: Evidence that neurons accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology. 2001; 38: 120-134. [DOI] [PubMed] [Google Scholar]
  6. D'Andrea MR, Reiser PA, Gumula NA, et al.: Application of triple-label immunohistochemistry to characterize inflammation in Alzheimer's disease brains. Biotech Histochem. 2001; 76: 97-106. [PubMed] [Google Scholar]
  7. Fonseca MI, Zhou J, Botto M, et al.: Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease. J Neurosci. 2004; 24(29): 6457-6465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Wang HY, Lee DHS, D'Andrea MR, et al.: ß-amyloid1-42 binds to a7 nicotinic acetylcholine receptor with high affinity: Implications for Alzheimer's disease pathology. J Biol Chem. 2000; 275(8): 5626-5632. [DOI] [PubMed] [Google Scholar]
  9. Weerth SH, Rus H, Shin ML, et al.: Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis. Am J Pathol. 2003; 163(3): 1069-1080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pasinetti GM: Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: The role of the complement system. Neurobiol Aging. 1996; 17(5): 707-716. [DOI] [PubMed] [Google Scholar]
  11. Rogers J, Cooper NR, Schultz J, et al.: Complement activation by ß-amyloid in Alzheimer's disease. Proc Natl Acad Sci USA. 1992; 89: 10016-10020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Loeffler DA, Camp DM, Schonberger MB, et al.: Early complement activation increases in the brain in some aged normal subjects. Neurobiol Aging. 2004; 25(8): 1001-1007. [DOI] [PubMed] [Google Scholar]
  13. Shen Y, Lue L-F, Yang L-B, et al.: Complement activation by neurofibrillary tangles in Alzheimer's disease. Neurosci Lett. 2001; 305: 165-168. [DOI] [PubMed] [Google Scholar]
  14. Singhrao SK, Neal JW, Morgan BP, et al.: Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease. Exp Neurol. 1999; 159: 362-376. [DOI] [PubMed] [Google Scholar]
  15. Barnum SR: Complement biosynthesis in the central nervous system. Crit Rev Oral Biol Med. 1995; 6: 132-146. [DOI] [PubMed] [Google Scholar]
  16. Mukherjee P, Pasinetti GM: The role of complement anaphylatoxin C5a in neurodegeneration: Implications in Alzheimer's disease. J Neuroimmunol. 2000; 105: 124-130. [DOI] [PubMed] [Google Scholar]
  17. Korb LC, Ahearn JM: C1q binding directly and specifically to surface belbs of aopototic human keratinocytes. J Immunol. 1997; 158: 4525-4528. [PubMed] [Google Scholar]
  18. Webster SD, Yang AJ, Margol L, et al.: Complement component C1q modulates the phagocytic behavior of microglia. Exp Neurol. 2000; 161: 127-138. [DOI] [PubMed] [Google Scholar]
  19. Neuroinflammation Working Group: Inflammation and Alzheimer's disease. Neurobiol Aging. 2000; 21: 383-421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Piddlesden SJ, Lassmann H, Zimprich F, et al.: The demyelinating potential of autoantibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am J Pathol. 1993; 143(2): 555-564. [PMC free article] [PubMed] [Google Scholar]
  21. Velazquez P, Cribbs DH, Poulos TL, et al.: Aspartate residue 7 in amyloid ß-protein is critical for classical complement pathway activation: Implications for Alzheimer's disease pathogenesis. Nat Med. 1997; 3(1): 77-79. [DOI] [PubMed] [Google Scholar]
  22. Spiegel K, Barnum SR, Emmerling ML. In Wood PL (ed.): Neuroinflammation: Mechanisms and Management. Totowa, NJ: Humana Press, 1997: 129-176. [Google Scholar]
  23. D'Andrea MR, Cole GM, Ard MD: The microglial phagocytic role with specific plaque types in the Alzheimer disease brain. Neurobiol Aging. 2004; 25(5): 675-683. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Alzheimer's Disease and Other Dementias are provided here courtesy of SAGE Publications

RESOURCES